Pharmacogenetic test kit PGX-5FU XL
for cancersfor genotypingDPD

pharmacogenetic test kit
pharmacogenetic test kit
pharmacogenetic test kit
Add to favorites
Compare this product


for cancers, for genotyping, for pharmacogenetics
Tested parameter
Sample type
whole blood, for DNA
Analysis mode
lateral flow, enzymatic, DNA analysis


The majority of the 3 to 5% of patients not adequately metabolizing 5-fluorouracil (5-FU) carry a specific mutation in their DPYD gene. While heterozygous patients should be given lower 5-FU doses, homozygous patients should receive alternative chemotherapeutic treatment.
*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.